Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1.0%
    Check dated 2025-04-30T06:23:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about an expanded access program for patisiran and the inclusion of new terminology related to TTR-mediated amyloidosis. Additionally, the version number has been updated from v2.14.4 to v2.15.0.
    Difference
    19%
    Check dated 2025-04-15T20:39:46.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-08T17:08:38.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-03-03T17:45:51.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-24T14:54:47.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-10T08:56:28.000Z thumbnail image

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.